NEC Joins the Connect Landmark Public-Private Initiative for Precision Cancer Medicine
NEC Corporation announced that it has joined a landmark public-private initiative, the Norwegian Precision Cancer Medicine Implementation Consortium, a collaboration between 22 key public and private partners for promoting precision cancer medicine. CONNECT is one of four interconnected initiatives in Norway that will ensure infrastructure and collaboration on diagnostics, clinical trials, implementation of advanced precision medicine and use of health data, e.g., for health economics analysis.
By joining the network of this Norwegian consortium and leveraging advanced real-world data, NEC hopes to reinforce and accelerate its personalized cancer immunotherapy activities.
Recommended AI News: Qualys and HCL Technologies Expand Partnership to Secure the Digital Transformation of Enterprises
While more than 30,000 Norwegians are diagnosed with cancer every year, and the incidence is still increasing, more precise treatments can save lives. CONNECT is a new initiative aiming to ensure that precision medicine reaches the patients.
“A serious cancer disease is an existential challenge for the individual. Cancer research gives hope. The pharmaceutical industry and the public health sector, clinicians and executive authorities, have to collaborate to offer new treatments, balancing the latest research with hospital operations,” says Asmund Flobak, Oncologist at St Olav’s Hospital, Trondheim University Hospital.
Recommended AI News: SymphonyAI Names Charles Zedlewski Operating Partner as Demand for Enterprise AI Accelerates
The new initiative is a direct response to Health Minister Bent Hoie’s political guidance to accelerate the implementation of precision medicine for Norwegian patients. It also responds to the Health Minister’s ambition to increase research and collaboration between public and private actors, including hospitals, other public stakeholders, the Norwegian Cancer Society, and the pharmaceutical industry.
CONNECT Founding Partners:
– Akershus universitetssykehus HF
– Helse Bergen HF
– Helse Stavanger HF
– St. Olavs hospital HF
– Universitetssykehuset Nord-Norge HF
– Oslo Universitetssykehus med Kreftregisteret og OUH Comprehensive Cancer Center
– Folkehelseinstituttet
– Oslo Cancer Cluster SA
– Kreftforeningen
– Legemiddelindustrien
– Roche Norge AS
– Bristol-Myers Squibb Norway Ltd NUF
– Novartis Norge AS
– Merck AB NUF
– Takeda AS
– Amgen AB Norge NUF
– AstraZeneca AS
– AbbVie AS
– Bayer AS
– PubGene AS
– Pfizer Norge AS
– NEC Corporation
Scrap copper merchants Copper scrap resource conservation Metal reclamation management
Copper cable scrap export, Metal scrap export regulations, Scrap Copper reuse
Metal recycling infrastructure Ferrous material marketing strategies Recycling iron waste
Ferrous scrap quality assurance, Iron waste collection, Scrap metal export procedures